by Daniela Steinberger
Genetisch bedingte Varianten von Proteinen des Medikamentenstoffwechsels können zu unerwünschten oder unzureichenden Arzneimittelwirkungen (UAW) führen.
bio.logis looks forward meeting and talking to you at the DMEA in Berlin. Please drop by our booth in hall 1.2/D-113 and get an update on our digital solutions for hospitals and labs to implement pharmacogenomics at the point of care. https://www.dmea.de/
„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“
"The Diagnostic Report Module is an enormous help for our scientific experts, who create complex reports on a daily basis. The support we received during the roll-out as well as the willingness and ability to adapt the solutions to our requirements and existing infrastructure are truly excellent."